Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LRRK2 | Q5S007 | 2/20 | 0.44 |
| ▸ | SOS1 | Q07889 | 3/20 | 0.44 |
| ▸ | KRAS | P01116 | 2/20 | 0.44 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.39 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.39 |
| ▸ | KDR | P35968 | 1/20 | 0.39 |
| ▸ | EPHB4 | P54760 | 1/20 | 0.39 |
| ▸ | PDE4D | Q08499 | 6/20 | 0.39 |
| ▸ | PDE4A | P27815 | 3/20 | 0.39 |
| ▸ | PDE4B | Q07343 | 3/20 | 0.39 |
| ▸ | PDE4C | Q08493 | 3/20 | 0.39 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.39 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.38 |
| ▸ | GRM5 | P41594 | 2/20 | 0.37 |
| ▸ | SYK | P43405 | 2/20 | 0.36 |
| ▸ | EGFR | P00533 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14579632 | 0.82 | KRAS (0.40) | LRRK2SOS1KRASERBB2EPHA2 | |
| SCHEMBL25131516 | 0.73 | EPHA2 (0.59) | SOS1KRASERBB2EPHA2KDR | |
| SCHEMBL29125432 | 0.71 | SOS1 (0.47) | SOS1KRASERBB2EPHA2KDR | |
| SCHEMBL29125430 | 0.71 | SOS1 (0.47) | SOS1KRASERBB2EPHA2KDR | |
| SCHEMBL25166319 | 0.70 | IRAK4 (0.50) | ERBB2EPHA2KDREPHB4PDE4D | |
| SCHEMBL25029414 | 0.70 | IRAK4 (0.50) | ERBB2EPHA2KDREPHB4PDE4D | |
| SCHEMBL15960727 | 0.69 | TLR8 (0.45) | KDREGFR | |
| SCHEMBL7219940 | 0.69 | ERBB2 (0.43) | SOS1KRASERBB2EPHA2KDR | |
| SCHEMBL6992855 | 0.69 | ERBB2 (0.43) | SOS1KRASERBB2EPHA2KDR | |
| SCHEMBL8522874 | 0.69 | LRRK2 (0.38) | LRRK2PDE4APDE4BGRM4IRAK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8426586-B2 | Using a acyl bromine compound; activation with phosphonacetic acid | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2013-04-23 | — | — | US | disclosed |